Diseases and Treatment
New Formulation of Cabotegravir for HIV Treatment Can be Dosed at Intervals of at Least 4 Months
Long-acting injectable therapies for HIV treatment have been an evolving modality that more companies are investigating, and have a variety of benefits including...
Potential Biomarkers of Long COVID
It remains a mystery in why acute COVID-19 infections can evolve into PASC or Long COVID. Medical science has been investigating some potential...
Lenacapavir Leads to Sustained Virologic Suppression in Heavily-Treated HIV Population
People with HIV (PWH) who experience multidrug resistance (MDR) have limited or no therapy options, which can leave their disease management very challenging.One...
The Norovirus Surge Across the United States
The Centers for Disease Control and Prevention (CDC) reports a notable spread of the norovirus in the Northeast United States, with the three-week...
Let’s Call March, Hepatitis Education Month
The World Health Organization's goal to Eliminate Viral Hepatitis by 2030 is an admirable one, but in response to this global campaign, we...
Top 5 Infectious Disease Stories: Week of February 25
This week, why measles and vibrio vulnificus infections are seeing outbreaks and increases in incidence rates; a medical association recommends fecal microbiota-based therapies...